Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Endocrinol Metab Clin North Am. 2020 Dec;49(4):741–757. doi: 10.1016/j.ecl.2020.08.002

Table 6.

Gonadotropin-Releasing Hormone Analogs used in Central Precocious Puberty in the United States

Formulation Frequency Dose Route
Leuprolide Monthly
3-monthly
0.2–0.3 mg/kg every 1 month
11.25 or 30 mg every 3 months
Intramuscular injection
Intramuscular injection
6-monthly 45 mg every 6 months (89) Subcutaneous injection
Triptorelin 6-monthly 22.5 mg every 6 months Intramuscular injection
Histrelin 1–2 years 50 mg every 1–2 years Subcutaneous implant